drugset / Trial / NCT05647252

General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery

NCT05647252

RandomizedParallel-groupOpen-labelPrevention

Summary

The general decolonization of the human body surface by industrial antiseptic agents, before elective surgery is recommended by the World Health Organization (WHO). A specific randomized-controlled trial specifically among high-risk adult orthopedic patients for infection has not been performed. In this single-center, prospective, randomized, and controlled superiority trial, which is planned over a period of two years, we target on an orthopedic patient population with an elevated risk for revision surgery and surgical site infections

Timeline

Start
2023-02-27
Primary completion
2024-11-28
Completion
2025-02-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Octenidine Small molecule Topical

Indications

No indication recorded.